» Articles » PMID: 16141330

Deletion of XPC Leads to Lung Tumors in Mice and is Associated with Early Events in Human Lung Carcinogenesis

Overview
Specialty Science
Date 2005 Sep 6
PMID 16141330
Citations 65
Authors
Affiliations
Soon will be listed here.
Abstract

Chromosome 3p and 1p deletions are among the most frequent genetic changes in human lung cancer and although candidate tumor suppressor genes have been identified in these regions, no causative correlations have been drawn between deletion or mutation of these and lung carcinogenesis. We identify XPC and Gadd45a as genes within each of these regions involved in lung tumor initiation and progression, respectively. One hundred percent of XPC-/- mice develop multiple spontaneous lung tumors with a minority progressing to non-small cell lung adenocarcinoma, occasionally with metastasis to adjacent lymph nodes. Deletion of Gadd45a alone does not lead to increased lung tumors in mice, but coupled with an XPC deletion, it results in lung tumor progression. Analysis of published data indicated allelic loss of XPC in most human lung tumors and allelic loss of Gadd45a in some human lung and other cancer types. Because DNA repair capacity is compromised in XPC+/- cells, it is possible that the loss of a single XPC allele in the human lung might confer a mutator phenotype. Coupled with cigarette carcinogens, decreased DNA repair would lead to additional mutations in genes such as p53 that are frequent targets in lung cancer.

Citing Articles

XPC Protects against Carcinogen-Induced Histologic Progression to Lung Squamous Cell Carcinoma by Reduced Basal Epithelial Cell Proliferation.

Sears C, Zhou H, Hulsey E, Aidoo B, Sandusky G, Al Nasrallah N Cancers (Basel). 2024; 16(8).

PMID: 38672576 PMC: 11048415. DOI: 10.3390/cancers16081495.


Mutational signature-based identification of DNA repair deficient gastroesophageal adenocarcinomas for therapeutic targeting.

Prosz A, Sahgal P, Huffman B, Sztupinszki Z, Morris C, Chen D NPJ Precis Oncol. 2024; 8(1):87.

PMID: 38589664 PMC: 11001913. DOI: 10.1038/s41698-024-00561-6.


A multiplexed in vivo approach to identify driver genes in small cell lung cancer.

Lee M, Cai H, Murray C, Li C, Shue Y, Andrejka L Cell Rep. 2023; 42(1):111990.

PMID: 36640300 PMC: 9972901. DOI: 10.1016/j.celrep.2023.111990.


Xeroderma Pigmentosum Complementation Group C (XPC): Emerging Roles in Non-Dermatologic Malignancies.

Al Nasrallah N, Wiese B, Sears C Front Oncol. 2022; 12:846965.

PMID: 35530314 PMC: 9069926. DOI: 10.3389/fonc.2022.846965.


GADD45 in Stress Signaling, Cell Cycle Control, and Apoptosis.

Humayun A, Fornace Jr A Adv Exp Med Biol. 2022; 1360:1-22.

PMID: 35505159 DOI: 10.1007/978-3-030-94804-7_1.


References
1.
Friedberg E, Bond J, Burns D, Cheo D, Greenblatt M, Meira L . Defective nucleotide excision repair in xpc mutant mice and its association with cancer predisposition. Mutat Res. 2000; 459(2):99-108. DOI: 10.1016/s0921-8777(99)00068-3. View

2.
Khan S, Muniz-Medina V, Shahlavi T, Baker C, Inui H, Ueda T . The human XPC DNA repair gene: arrangement, splice site information content and influence of a single nucleotide polymorphism in a splice acceptor site on alternative splicing and function. Nucleic Acids Res. 2002; 30(16):3624-31. PMC: 134237. DOI: 10.1093/nar/gkf469. View

3.
Peng H, Xu F, Pershad R, Hunt K, Frazier M, Berchuck A . ARHI is the center of allelic deletion on chromosome 1p31 in ovarian and breast cancers. Int J Cancer. 2000; 86(5):690-4. DOI: 10.1002/(sici)1097-0215(20000601)86:5<690::aid-ijc14>3.0.co;2-k. View

4.
Girard L, Zochbauer-Muller S, Virmani A, Gazdar A, Minna J . Genome-wide allelotyping of lung cancer identifies new regions of allelic loss, differences between small cell lung cancer and non-small cell lung cancer, and loci clustering. Cancer Res. 2000; 60(17):4894-906. View

5.
Pfeifer G, Yoon J, Liu L, Tommasi S, Wilczynski S, Dammann R . Methylation of the RASSF1A gene in human cancers. Biol Chem. 2002; 383(6):907-14. DOI: 10.1515/BC.2002.097. View